MetaADEDB 2.0 @ LMMD
Naloxegol oxalate
(MNYIRXLCPODKLG-VUTNLTPYSA-N)
Structure
SMILES
OC(=O)C(=O)O.COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC=C)ccc1O)O
Molecular Formula:
C36H55NO15
Molecular Weight:
741.820
Log P:
0.9570
Hydrogen Bond Acceptor:
16
Hydrogen Bond Donor:
4
TPSA:
201.37
CAS Number(s):
1354744-91-4
Synonym(s)
1.
Naloxegol oxalate
External Link(s)
PubChem Compound56959086
CHEMBLCHEMBL2219416
KEGGdr:D10375
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainFAERS: 4US FAERS
2Back PainFAERS: 3US FAERS
3DiverticulitisFAERS: 2US FAERS
4DizzinessFAERS: 2US FAERS
5SepsisFAERS: 2US FAERS
6Acute kidney injuryFAERS: 1US FAERS
7AphasiaFAERS: 1US FAERS
8ArthralgiaFAERS: 1US FAERS
9AstheniaFAERS: 1US FAERS
10Atrial FibrillationFAERS: 1US FAERS
11Blood potassium decreasedFAERS: 1US FAERS
12Bone lesionFAERS: 1US FAERS
13Cerebrovascular accidentFAERS: 1US FAERS
14DeliriumFAERS: 1US FAERS
15Disease ProgressionFAERS: 1US FAERS
16DysphoniaFAERS: 1US FAERS
17Electrolyte imbalanceFAERS: 1US FAERS
18FatigueFAERS: 1US FAERS
19Febrile NeutropeniaFAERS: 1US FAERS
20Hospice CareFAERS: 1US FAERS
21HydrocephalusFAERS: 1US FAERS
22HypotensionFAERS: 1US FAERS
23IncoherentFAERS: 1US FAERS
24Malignant neoplasm progressionFAERS: 1US FAERS
25MyalgiaFAERS: 1US FAERS
26Neck PainFAERS: 1US FAERS
27PancytopeniaFAERS: 1US FAERS
28ParotitisFAERS: 1US FAERS
29Pathological fractureFAERS: 1US FAERS
30PneumoniaFAERS: 1US FAERS
31Respiratory DepressionFAERS: 1US FAERS
32Respiratory FailureFAERS: 1US FAERS
33Unresponsive to stimuliFAERS: 1US FAERS
34VomitingFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.